Comprehensive review on pain management pharmaceuticals market

Research and Markets (http://www.researchandmarkets.com/research/90de9b/pain_management) has announced the addition of the “Pain Management - Global Trends” report to their offering.

Stallergenes granted European approval to market Oralair

Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.

Parkinson disease drug pipeline report from Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/4bfafd/parkinson_disease) has announced the addition of the “Parkinson Disease Therapy Area Pipeline Report” report to their offering.

European Commission approves MICARDIS medication for CV protection

MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients [...]

Detailed report on Alzheimer disease drug pipeline

Research and Markets (http://www.researchandmarkets.com/research/afda44/alzheimer_disease) has announced the addition of the “Alzheimer Disease Therapy Area Pipeline Report” report to their offering.

Varicose veins drug pipeline report from Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/818d53/varicose_veins_the) has announced the addition of the “Varicose Veins Therapy Area Pipeline Report” report to their offering.

Health Canada announces recent changes made to heparin manufacturing standards

Health Canada is informing health care professionals and Canadians of recent changes to heparin manufacturing standards in the United States that will result in a decrease in the potency of certain heparin products by about 10 per cent.

Report on global osteoporosis therapeutics market

Research and Markets (http://www.researchandmarkets.com/research/2070d2/osteoporosis_thera) has announced the addition of the “Osteoporosis Therapeutics - A Global Market Perspective” report to their offering.

NCKU, ScinoPharm Taiwan sign MOU to establish university-industry cooperation

National Cheng Kung University (NCKU), Taiwan signed a MOU with ScinoPharm Taiwan Ltd. on Nov. 24th.

Patients Unlikely To Benefit From Free E-Samples Of Prescription Drugs

Search the Internet to learn about your asthma, high cholesterol or other common disorder, and odds are you’ll be directed to a pharmaceutical company-sponsored Web homepage. There you’ll often find an offer for a free sample or a one-time discount on a top-selling prescription medication. Is it a good deal? Not according [...]